Desmoid Tumours
On this page
Direct answer
Desmoid tumours are deep musculoaponeurotic fibromatoses — clonal myofibroblastic proliferations that are histologically benign and never metastasise, yet infiltrate locally and recur aggressively after excision. Most are sporadic, driven by beta-catenin (CTNNB1) mutations or trauma, while intra-abdominal desmoids are a hallmark of familial adenomatous polyposis and Gardner syndrome, in which mesenteric fibromatosis after colectomy is a leading cause of death. They arise as abdominal wall tumours (classically in the rectus of young women during or after pregnancy), extra-abdominal tumours around limb girdles, and intra-abdominal or mesenteric tumours. Treatment has moved from reflex surgery towards an initial watch-and-wait strategy for many, reserving wide excision with negative margins, radiotherapy, and medical therapy with anti-oestrogens plus non-steroidal anti-inflammatory drugs or cytotoxics for progressive disease.
What you must remember
- Definition: locally aggressive fibroblastic proliferation with no metastatic potential but a strong tendency to local infiltration and recurrence (commonly quoted recurrence around 20–50 per cent after excision).
- Genetics: sporadic tumours carry CTNNB1 (beta-catenin) mutations; FAP-associated ones follow APC mutations, and desmoid disease is part of Gardner syndrome.
- Site types: abdominal wall (rectus sheath, young women, pregnancy-related, oestrogen association), extra-abdominal (shoulder and limb girdle), and intra-abdominal (mesentery and pelvis, typically FAP).
- Clinical picture: a slow-growing, firm, non-tender mass that gradually fixes; intra-abdominal ones present with pain, obstruction, or a mesenteric mass after prophylactic colectomy.
- Imaging and biopsy: MRI defines extent; core-needle biopsy confirms with beta-catenin nuclear immunostaining; beware the overlap with sarcoma on imaging.
- Management per current practice: observation first for asymptomatic tumours whose resection would be morbid, since some stabilise or regress; wide excision with negative margins when feasible; radiotherapy for positive margins or inoperable extra-abdominal disease.
- Medical therapy: tamoxifen or other anti-oestrogens combined with NSAIDs such as sulindac; chemotherapy (methotrexate with vinblastine, or anthracycline-based) and tyrosine kinase inhibitors for progressive disease.
Common confusion
The exam pitfall is calling a desmoid a sarcoma and staging for metastasectomy. Desmoids never metastasise, so radical mutilating surgery or routine chemotherapy for 'cure' is wrong; the danger is local — recurrence and, in mesenteric disease, obstruction of ureters or bowel and erosion into vessels. Conversely, missing a soft-tissue sarcoma by assuming 'desmoid' in a deep, enlarging 8 cm thigh mass is the mirror-image error; MRI and planned biopsy at a sarcoma centre resolve it.
Exam-focused takeaway
Questions link Gardner syndrome with desmoids alongside sebaceous cysts and osteomas, ask the mutation (APC in FAP, CTNNB1 sporadic), and ask about behaviour — benign histology, no metastasis, local aggression. A second format is the young woman with a firm parietal mass after pregnancy: diagnosis desmoid, first-line management now often observation, with surgery for resectable progressive disease. Remember anti-oestrogen plus NSAID as the classic medical answer.
Frequently asked questions
Do desmoid tumours metastasise?
No; they are benign fibroblastic proliferations without metastatic potential, but they infiltrate locally and can kill through local complications, especially in the mesentery.
Why are desmoids important in familial adenomatous polyposis?
Intra-abdominal desmoid disease is strongly associated with FAP and Gardner syndrome, and after prophylactic colectomy it is a leading cause of morbidity and mortality in these patients.
What is the first-line strategy for many desmoids today?
An initial period of observation ('watch and wait') is increasingly preferred for asymptomatic or slowly growing tumours, since some stabilise spontaneously and surgery carries morbidity and recurrence risk.
Which medical agents are used for progressive desmoids?
Anti-oestrogens such as tamoxifen combined with NSAIDs like sulindac, escalating to low-toxicity chemotherapy or tyrosine kinase inhibitors for relentlessly progressive disease.
How do abdominal wall desmoids typically present?
As a firm, slowly enlarging, painless mass in the rectus region of a young woman, often during or after pregnancy, confirmed by MRI and core biopsy showing beta-catenin positivity.